|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2008-6-27
|
|
pubmed:abstractText |
PET-FDG and USPIO-enhanced MRI are increasingly being used in depicting carotid atheroma inflammation--a risk factor for the high risk plaque. Their combined use has not been previously reported.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1532-2165
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
36
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
53-5
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:18396074-Aged,
pubmed-meshheading:18396074-Carotid Stenosis,
pubmed-meshheading:18396074-Contrast Media,
pubmed-meshheading:18396074-Dextrans,
pubmed-meshheading:18396074-Ferumoxytol,
pubmed-meshheading:18396074-Fluorodeoxyglucose F18,
pubmed-meshheading:18396074-Humans,
pubmed-meshheading:18396074-Iron,
pubmed-meshheading:18396074-Magnetic Resonance Angiography,
pubmed-meshheading:18396074-Magnetite Nanoparticles,
pubmed-meshheading:18396074-Male,
pubmed-meshheading:18396074-Middle Aged,
pubmed-meshheading:18396074-Oxides,
pubmed-meshheading:18396074-Positron-Emission Tomography,
pubmed-meshheading:18396074-Predictive Value of Tests,
pubmed-meshheading:18396074-Radiopharmaceuticals,
pubmed-meshheading:18396074-Severity of Illness Index,
pubmed-meshheading:18396074-Stroke
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Combined PET-FDG and USPIO-enhanced MR imaging in patients with symptomatic moderate carotid artery stenosis.
|
|
pubmed:affiliation |
Cambridge Vascular Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. tt279@cam.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Case Reports,
Research Support, Non-U.S. Gov't
|
